Terms: = Thyroid cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR
100 results:
1. Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation.
Lee M; Morris LG
Oncotarget; 2024 Jan; 15():36-48. PubMed ID: 38275291
[TBL] [Abstract] [Full Text] [Related]
2. Chimeric antigen receptor-based immunotherapy in breast cancer: Recent progress in China.
Yu T; Lu Y; Fang J; Jiang X; Lu Y; Zheng J; Shang X; Shen H; Fu P
Cancer; 2024 Apr; 130(S8):1378-1391. PubMed ID: 37950749
[TBL] [Abstract] [Full Text] [Related]
3. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract] [Full Text] [Related]
4. Metabolic challenges and interventions in car T cell therapy.
Peng JJ; Wang L; Li Z; Ku CL; Ho PC
Sci Immunol; 2023 Apr; 8(82):eabq3016. PubMed ID: 37058548
[TBL] [Abstract] [Full Text] [Related]
5. Massively parallel knock-in engineering of human T cells.
Dai X; Park JJ; Du Y; Na Z; Lam SZ; Chow RD; Renauer PA; Gu J; Xin S; Chu Z; Liao C; Clark P; Zhao H; Slavoff S; Chen S
Nat Biotechnol; 2023 Sep; 41(9):1239-1255. PubMed ID: 36702900
[TBL] [Abstract] [Full Text] [Related]
6. Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression.
Gravina A; Tediashvili G; Rajalingam R; Quandt Z; Deisenroth C; Schrepfer S; Deuse T
Nat Biotechnol; 2023 May; 41(5):717-727. PubMed ID: 36593395
[TBL] [Abstract] [Full Text] [Related]
7. BLIMP1 and NR4A3 transcription factors reciprocally regulate antitumor car T cell stemness and exhaustion.
Jung IY; Narayan V; McDonald S; Rech AJ; Bartoszek R; Hong G; Davis MM; Xu J; Boesteanu AC; Barber-Rotenberg JS; Plesa G; Lacey SF; Jadlowsky JK; Siegel DL; Hammill DM; Cho-Park PF; Berger SL; Haas NB; Fraietta JA
Sci Transl Med; 2022 Nov; 14(670):eabn7336. PubMed ID: 36350986
[TBL] [Abstract] [Full Text] [Related]
8. Bilateral tympanic myxoma: A carE case report.
Gallois Y; Siegfried A; Dupin-Deguine D; Deguine O
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Jan; 140(1):43-45. PubMed ID: 36333210
[TBL] [Abstract] [Full Text] [Related]
9. A novel parallel overlapping mode for complete ablation of large benign thyroid nodules in a single-session radiofrequency ablation.
Wu T; Zheng B; Tan L; Yin T; Lian Y; Xu S; Ye J; Ren J
Front Endocrinol (Lausanne); 2022; 13():915303. PubMed ID: 35992133
[TBL] [Abstract] [Full Text] [Related]
10. Adrenal Cortical carcinoma and Additional Rare Pathologic Findings in Multi-Organs in a Birt-Hogg-Dubé Syndrome Patient: With an Emphasis on the Molecular Characteristics of Adrenal Cortical carcinoma.
Kim D; Murvelashvili N; Hamidi O; Jia L
Int J Surg Pathol; 2023 Aug; 31(5):689-694. PubMed ID: 35946080
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Application of C-TIRADS Category and Contrast-Enhanced Ultrasound in Differential Diagnosis of Solid thyroid Nodules Measuring ≥1 cm.
Jin Z; Zhu Y; Lei Y; Yu X; Jiang N; Gao Y; Cao J
Med Sci Monit; 2022 Jun; 28():e936368. PubMed ID: 35668611
[TBL] [Abstract] [Full Text] [Related]
12. T Cells Engineered to Express Immunoreceptors Targeting the Frequently Expressed Medullary thyroid cancer Antigens Calcitonin, CEA, and RET M918T.
Erickson TA; Shih YP; Fass J; Jang M; Tran E
Thyroid; 2022 Jul; 32(7):789-798. PubMed ID: 35587601
[No Abstract] [Full Text] [Related]
13. Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2.
Das R; Ghosh Chowdhury M; Raundal S; Jadhav J; Kumar N; Patel S; Shard A
Gene; 2022 May; 822():146354. PubMed ID: 35189247
[TBL] [Abstract] [Full Text] [Related]
14. Switch receptor T3/28 improves long-term persistence and antitumor efficacy of car-T cells.
Zhao S; Wang C; Lu P; Lou Y; Liu H; Wang T; Yang S; Bao Z; Han L; Liang X; Ma C; Gao L
J Immunother Cancer; 2021 Nov; 9(12):. PubMed ID: 34853180
[TBL] [Abstract] [Full Text] [Related]
15. Tandem car-T cells targeting FOLR1 and MSLN enhance the antitumor effects in ovarian cancer.
Liang Z; Dong J; Yang N; Li SD; Yang ZY; Huang R; Li FJ; Wang WT; Ren JK; Lei J; Xu C; Wang D; Wang YZ; Liang ZQ
Int J Biol Sci; 2021; 17(15):4365-4376. PubMed ID: 34803504
[TBL] [Abstract] [Full Text] [Related]
16. car-T Cells Targeting TSHR Demonstrate Safety and Potent Preclinical Activity Against Differentiated thyroid cancer.
Li H; Zhou X; Wang G; Hua D; Li S; Xu T; Dong M; Cui X; Yang X; Wu Y; Cai M; Liao X; Zhang T; Yang Z; Du Y; Li X
J Clin Endocrinol Metab; 2022 Mar; 107(4):1110-1126. PubMed ID: 34751400
[TBL] [Abstract] [Full Text] [Related]
17. car-T therapy: Prospects in targeting cancer stem cells.
Cui X; Liu R; Duan L; Cao D; Zhang Q; Zhang A
J Cell Mol Med; 2021 Nov; 25(21):9891-9904. PubMed ID: 34585512
[TBL] [Abstract] [Full Text] [Related]
18. Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy.
Gonzalez-Pastor R; Hernandez Y; Gimeno M; de Martino A; Man YKS; Hallden G; Quintanilla M; de la Fuente JM; Martin-Duque P
Acta Biomater; 2021 Oct; 134():593-604. PubMed ID: 34325075
[TBL] [Abstract] [Full Text] [Related]
19. Contrast agent retention features in contrast-enhanced ultrasound: diagnostic performance for the prediction of papillary thyroid carcinoma.
Jin Z; Zhu Y; Xie F; Zhang Y; Li N; Luo Y; Cao J
Clin Imaging; 2021 Dec; 80():131-138. PubMed ID: 34315016
[TBL] [Abstract] [Full Text] [Related]
20. Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
Dolina J; Kunovsky L; Kroupa R; Stary K; Jabandziev P; Nesporova T; Maca K; Andrasina T; Marek F; Kala Z; Vaculova J; Said D; Zapletalova M; Lochman J; Palova Noskova H; Slaby O; Izakovicova Holla L; Borilova Linhartova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):228-235. PubMed ID: 34282806
[TBL] [Abstract] [Full Text] [Related]
[Next]
